Dani Instruments SpA and Labindia Instruments Pvt Ltd have announced an exclusive distribution agreement.
Dani Instruments SpA (Cologno Monzese, Italy) and Labindia Instruments Pvt Ltd (Thane, India) have announced an exclusive distribution agreement. The deal sees Labindia become the exclusive distributor for the gas chromatography (GC) portfolio of Dani Instruments within India.
“Labindia is a great partner and we expect they will deliver a strong growth of our brand in this country,” said Massimiliano Saini Fasanotti, CEO of Dani Instruments SpA. He continued, “They have the scale, infrastructure, reputation, experience, and complementary product portfolio to make Dani a market leader in the Indian market. We are happy that Labindia recognized the quality, robustness, innovation, and breadth of our products.”
Under the terms of the agreement, Labindia will distribute Dani products. There is also scope for the distribution agreement to be expanded with additional products in the near future.
“Labindia is committed to provide its customers advanced chromatographic solutions,” said Shriram Bhalerao, Managing Director Labindia Instruments. “The Dani gas chromatographic portfolio includes unique solutions to address the most demanding customers’ needs. Dani’s portfolio is a perfect fit with our current offer in the analytical market,” added Shriram.
Both companies hope that their combined reputation and experience as well as complementary product profiles can yield a prominent place within the Indian analytical chemistry market.
For more information please visit www.dani-instruments.com or http://www.labindia.com/
New Study Uses MSPE with GC–MS to Analyze PFCAs in Water
January 20th 2025Scientists from the China University of Sciences combined magnetic solid-phase extraction (MSPE) with gas chromatography–mass spectrometry (GC–MS) to analyze perfluoro carboxylic acids (PFCAs) in different water environments.
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ion used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
A Guide To Finding the Ideal Syringe and Needle
January 20th 2025Hamilton has produced a series of reference guides to assist science professionals in finding the best-suited products and configurations for their applications. The Syringe and Needle Reference Guide provides detailed information on Hamilton Company’s full portfolio of syringes and needles. Everything from cleaning and preventative maintenance to individual part numbers are available for review. It also includes selection charts to help you choose between syringe terminations like cemented needles and luer tips.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Oasis or Sand Dune? Isolation of Psychedelic Compounds
January 20th 2025Magic mushrooms, once taboo, have recently experienced a renaissance. This new awakening is partially due to new findings that indicate the effects of psilocybin, and its dephosphorylated cousin psilocin may produce long lasting results for patients who might be struggling with anxiety, depression, alcohol and drug abuse, and post-traumatic stress disorder. Hamilton Company has developed a methodology for the isolation and identification of 5 common psychedelic compounds used in the potential treatment of disease. The PRP-1 HPLC column resin remains stable in the harsh alkaline conditions ideal for better separations.